Table 1 Sample assignment in signalling perturbation dataset.
From: A pluripotent stem cell atlas of multilineage differentiation
BC Line | Condition | Library 1 | Library 2 | Library 3 | Concentration | Treatment | Source |
|---|---|---|---|---|---|---|---|
BC01 | Control | Day 5 | Day 2 | Day 9 | — | — | — |
BC02 | Low XAV | Day 5 | Day 2 | Day 9 | 1uM | XAV939 | STEMCELL Technologies #72674 |
BC03 | XAV | Day 5 | — | Day 9 | 5uM | XAV939 | STEMCELL Technologies #72674 |
BC04 | CHIR | Day 5 | Day 2 | Day 9 | 3uM | CHIR99021 | STEMCELL Technologies #72054 |
BC05 | Low Dorso | Day 5 | Day 2 | Day 9 | 0.4uM | Dorsomorphin | Sigma-Aldrich #P5499 |
BC06 | Dorso | Day 5 | Day 2 | Day 9 | 4uM | Dorsomorphin | Sigma-Aldrich #P5499 |
BC07 | K02288 | Day 5 | Day 2 | Day 9 | 0.5uM | K02288 | Cayman Chemical #16678 |
BC08 | BMP4 | Day 5 | Day 2 | Day 9 | 10 ng/mL | Recombinant Human BMP4 | R&D Systems #RDS314BP010 |
BC11 | VEGF | Day 5 | Day 2 | Day 9 | 100 ng/mL | Recombinant Human VEGF | R&D Systems #RDSPRD29350 |
BC10 | Control | Day 2 | Day 9 | Day 5 | — | — | — |
BC09 | Low XAV | Day 2 | Day 9 | Day 5 | 1uM | XAV939 | STEMCELL Technologies #72674 |
BC12 | XAV | Day 2 | Day 9 | Day 5 | 5uM | XAV939 | STEMCELL Technologies #72674 |
BC13 | CHIR | Day 2 | Day 9 | Day 5 | 3uM | CHIR99021 | STEMCELL Technologies #72054 |
BC14 | Low Dorso | Day 2 | Day 9 | Day 5 | 0.4uM | Dorsomorphin | Sigma-Aldrich #P5499 |
BC15 | Dorso | Day 2 | Day 9 | Day 5 | 4uM | Dorsomorphin | Sigma-Aldrich #P5499 |
BC16 | K02288 | Day 2 | Day 9 | Day 5 | 0.5uM | K02288 | Cayman Chemical #16678 |
BC17 | BMP4 | Day 2 | Day 9 | Day 5 | 10 ng/mL | Recombinant Human BMP4 | R&D Systems #RDS314BP010 |
BC18 | VEGF | Day 2 | Day 9 | Day 5 | 100 ng/mL | Recombinant Human VEGF | R&D Systems #RDSPRD29350 |
